GR1001161B - Αναστολη της προσκολλησης των λεμφοκυτταρων στο αγγειακο ενδοθηλιο με τη χρησιμοποιηση μιας αλληλεπιδρασης νεου υποδοχεα εξωκυτταρικης μητρας-προσδετη. - Google Patents
Αναστολη της προσκολλησης των λεμφοκυτταρων στο αγγειακο ενδοθηλιο με τη χρησιμοποιηση μιας αλληλεπιδρασης νεου υποδοχεα εξωκυτταρικης μητρας-προσδετη.Info
- Publication number
- GR1001161B GR1001161B GR900100648A GR900100648A GR1001161B GR 1001161 B GR1001161 B GR 1001161B GR 900100648 A GR900100648 A GR 900100648A GR 900100648 A GR900100648 A GR 900100648A GR 1001161 B GR1001161 B GR 1001161B
- Authority
- GR
- Greece
- Prior art keywords
- present
- receptor
- adhesion
- lymphocytes
- inhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
- C07K14/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
H παρούσα εφεύρεση αναφέρεται σε μια μέθοδο για την αναστολή της προσκόλλησης του ενός κυττάρου σε ένα άλλο που περιλαμβάνει την παρεμβολή στην αλληλεπίδραση μεταξύ του υποδοχέα εξωκυτταρικής μήτρας και του προσδέτη του. Η εφεύρεση βασίζεται στην ανακάλυψη ότι ο α4β1 υποδοχέας εξωκυτταρικής μήτρας προάγει την προσκόλληση των λεμφοκυττάρων σε ενδοθηλιακά κύτταρα μέσω της σύνδεσης σε μια καθορισμένη πεπτιδική αλληλουχία. Πριν από την παρούσα εφέρευση, δεν είχε ταυτοποιηθεί ο προσδέτης του α4β1 υποδοχέα, ούτε ήταν γνωστή η λειτουργία του α4β1 υποδοχέα επί της λεμφοκυτταρικής προσκόλλησης. Παρεμποδίζοντας την αλληλεπίδραση μεταξύ α4β1 υποδοχέα και των προσδετών του με την χρησιμοποίηση αντισωμάτων ή καθορισμένων πεπτιδικών αλληλουχιών, η παρούσα εφεύρεση επιτρέπει, για πρώτη φορά, την ειδική παρεμβολή στην μετακίνηση των λεμφοκυττάρων μέσα από το αγγειακό ενδοθήλιο και προς τους ιστούς. Η παρούσα εφεύρεση, επομένως, έχει ιδιαίτερη κλινική χρησιμότητα στην καταστολή των ανόσων αποκρίσεων; σε διάφορες ειδικές ενσωματώσεις της εφεύρεσης, η προσκόλληση των λεμφοκυττάρων στο ενδοθήλιο μπορεί να ανασταλλεί συστηματικά, ή μπορεί, εναλλακτικά, να εντοπισθεί σε ειδικούς ιστούς ή περιγεγραμμένες επιφάνειες. Κατά συνέπεια, η παρούσα εφεύρεση προβλέπει για την θεραπεία ασθενειών που περιλαμβάνουν αυτοάνοσες αποκρίσεις όπως άλλων χρόνιων ή υποτροπιαζουσών ενεργοποιήσεων του άνοσου συστήματος, περιλαμβάνοντας αλλεργία, άσθμα, και χρόνιες φλεγμονώδεις καταστάσεις του δέρματος. ω
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40238989A | 1989-09-01 | 1989-09-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GR900100648A GR900100648A (en) | 1992-01-20 |
| GR1001161B true GR1001161B (el) | 1993-05-24 |
Family
ID=23591680
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR930100041A GR1001372B (el) | 1989-09-01 | 1990-08-28 | Αναστολή της προσκόλλησης λεμφοκυττάρων στο αγγειακό ενδοθήλιο με την χρησιμοποίηση μιάς αλληλεπίδρασης νέου υποδοχέα εξωκυτταρικής μήτρας-προσδέτη. |
| GR900100648A GR1001161B (el) | 1989-09-01 | 1990-08-28 | Αναστολη της προσκολλησης των λεμφοκυτταρων στο αγγειακο ενδοθηλιο με τη χρησιμοποιηση μιας αλληλεπιδρασης νεου υποδοχεα εξωκυτταρικης μητρας-προσδετη. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR930100041A GR1001372B (el) | 1989-09-01 | 1990-08-28 | Αναστολή της προσκόλλησης λεμφοκυττάρων στο αγγειακό ενδοθήλιο με την χρησιμοποίηση μιάς αλληλεπίδρασης νέου υποδοχέα εξωκυτταρικής μήτρας-προσδέτη. |
Country Status (19)
| Country | Link |
|---|---|
| EP (2) | EP0489837B2 (el) |
| JP (1) | JP3357359B2 (el) |
| KR (1) | KR100188459B1 (el) |
| AT (1) | ATE253642T1 (el) |
| AU (1) | AU654657B2 (el) |
| CA (1) | CA2065292C (el) |
| DD (1) | DD297562A5 (el) |
| DE (3) | DE122006000044I2 (el) |
| DK (1) | DK0489837T4 (el) |
| ES (1) | ES2210225T5 (el) |
| FI (2) | FI116793B (el) |
| GR (2) | GR1001372B (el) |
| IE (2) | IE903169A1 (el) |
| IL (3) | IL113261A (el) |
| LU (1) | LU91273I2 (el) |
| NL (1) | NL300240I2 (el) |
| NZ (1) | NZ235131A (el) |
| PT (1) | PT95180A (el) |
| WO (1) | WO1991003252A1 (el) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5730978A (en) * | 1989-09-01 | 1998-03-24 | Fred Hutchinson Cancer Research Center | Inhibition of lymphocyte adherence with α4β1-specific antibodies |
| US7238668B1 (en) | 1989-09-01 | 2007-07-03 | Fred Hutchinson Cancer Research Center | Inhibition of lymphocyte adherence with CS-1-peptides and fragments thereof |
| US6033665A (en) * | 1989-09-27 | 2000-03-07 | Elan Pharmaceuticals, Inc. | Compositions and methods for modulating leukocyte adhesion to brain endothelial cells |
| US5610148A (en) * | 1991-01-18 | 1997-03-11 | University College London | Macroscopically oriented cell adhesion protein for wound treatment |
| US5629287A (en) * | 1991-01-18 | 1997-05-13 | University College London | Depot formulations |
| AU3420693A (en) * | 1991-12-24 | 1993-07-28 | Fred Hutchinson Cancer Research Center | Competitive inhibition of high-avidity alpha4-beta1 receptor using tripeptide ldv |
| CA2127462C (en) * | 1992-01-13 | 1999-03-23 | Roy R. Lobb | Treatment for asthma |
| US5871734A (en) * | 1992-01-13 | 1999-02-16 | Biogen, Inc. | Treatment for asthma with VLA-4 blocking agents |
| US5932214A (en) * | 1994-08-11 | 1999-08-03 | Biogen, Inc. | Treatment for inflammatory bowel disease with VLA-4 blockers |
| IL102646A (en) * | 1992-07-26 | 1996-05-14 | Yeda Res & Dev | Non-peptidic surrogates of the ldv sequence and pharmaceutical compositions comprising them |
| EP0670735B1 (en) | 1992-11-13 | 1997-04-02 | Board Of Regents Of The University Of Washington | Peripheralization of hematopoietic stem cells |
| JP3593343B2 (ja) † | 1993-02-09 | 2004-11-24 | バイオジェン インコーポレイテッド | インシュリン依存型糖尿病の治療 |
| AU688307B2 (en) † | 1993-03-18 | 1998-03-12 | N.V. Innogenetics S.A. | Process for typing HLA-B using specific primers and probes sets |
| ZA947006B (en) * | 1993-09-15 | 1995-05-02 | Univ Emory | Method of inhibiting binding of reticulocytes to endothelium by interfering with vla-4/vcam-1 interactions |
| US5821231A (en) * | 1993-12-06 | 1998-10-13 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using same |
| US5770573A (en) * | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| US5936065A (en) * | 1993-12-06 | 1999-08-10 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| WO1995015973A1 (en) * | 1993-12-06 | 1995-06-15 | Cytel Corporation | Cs-1 peptidomimetics, compositions and methods of using the same |
| US7435802B2 (en) | 1994-01-25 | 2008-10-14 | Elan Pharaceuticals, Inc. | Humanized anti-VLA4 immunoglobulins |
| WO1995019790A1 (en) * | 1994-01-25 | 1995-07-27 | Athena Neurosciences, Inc. | Humanized antibodies against leukocyte adhesion molecule vla-4 |
| US5840299A (en) * | 1994-01-25 | 1998-11-24 | Athena Neurosciences, Inc. | Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| FR2724393A1 (fr) * | 1994-09-12 | 1996-03-15 | Inst Nat Sante Rech Med | Obtention d'un anticorps monoclonal recombinant humanise a partir d'un anticorps monoclonal murin, sa production en cellules d'insecte, et ses utilisations |
| WO1997035557A1 (en) * | 1996-03-22 | 1997-10-02 | Kao Corporation | External skin-care composition |
| US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
| EP1485127B1 (en) | 2002-02-25 | 2011-06-08 | Elan Pharmaceuticals, Inc. | Administration of agents for the treatment of inflammation |
| US7125650B2 (en) | 2004-07-20 | 2006-10-24 | Roberts David H | Method for bump exposing relief image printing plates |
| UA116189C2 (uk) | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА |
| EP3311834A1 (en) | 2011-05-02 | 2018-04-25 | Millennium Pharmaceuticals, Inc. | Formulation for anti-alpha4beta7 antibody |
| EP4597110A3 (en) * | 2024-02-05 | 2025-09-10 | Universita' degli studi di Brescia | Hypermobile ehlers-danlos syndrome, hypermobility spectrum disorders and osteoarthritis plasma markers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4578079A (en) * | 1982-08-04 | 1986-03-25 | La Jolla Cancer Research Foundation | Tetrapeptide |
| WO1990008833A1 (en) * | 1989-02-02 | 1990-08-09 | Massachusetts Institute Of Technology | Expression of recombinant fibronectin in genetically engineered cells |
-
1990
- 1990-08-27 IL IL11326190A patent/IL113261A/en active IP Right Grant
- 1990-08-27 IL IL95501A patent/IL95501A/xx active IP Right Grant
- 1990-08-28 GR GR930100041A patent/GR1001372B/el not_active IP Right Cessation
- 1990-08-28 GR GR900100648A patent/GR1001161B/el not_active IP Right Cessation
- 1990-08-31 DE DE122006000044C patent/DE122006000044I2/de active Active
- 1990-08-31 DE DE1990634116 patent/DE122006000044I1/de active Pending
- 1990-08-31 NZ NZ235131A patent/NZ235131A/xx unknown
- 1990-08-31 CA CA002065292A patent/CA2065292C/en not_active Expired - Lifetime
- 1990-08-31 IE IE316990A patent/IE903169A1/en active IP Right Review Request
- 1990-08-31 ES ES90913598.0T patent/ES2210225T5/es not_active Expired - Lifetime
- 1990-08-31 PT PT95180A patent/PT95180A/pt not_active Application Discontinuation
- 1990-08-31 DK DK90913598.0T patent/DK0489837T4/da active
- 1990-08-31 JP JP51276390A patent/JP3357359B2/ja not_active Expired - Lifetime
- 1990-08-31 IE IE20040028A patent/IE20040028A1/en not_active IP Right Cessation
- 1990-08-31 WO PCT/US1990/004978 patent/WO1991003252A1/en not_active Ceased
- 1990-08-31 DE DE69034116.4T patent/DE69034116T3/de not_active Expired - Lifetime
- 1990-08-31 EP EP90913598.0A patent/EP0489837B2/en not_active Expired - Lifetime
- 1990-08-31 KR KR1019920700621A patent/KR100188459B1/ko not_active Expired - Fee Related
- 1990-08-31 AT AT90913598T patent/ATE253642T1/de active
- 1990-08-31 EP EP20030017578 patent/EP1366769A1/en not_active Withdrawn
- 1990-08-31 AU AU63542/90A patent/AU654657B2/en not_active Expired
- 1990-09-03 DD DD90343788A patent/DD297562A5/de unknown
-
1992
- 1992-02-28 FI FI920899A patent/FI116793B/fi active IP Right Grant
-
1995
- 1995-04-05 IL IL11326195A patent/IL113261A0/xx unknown
-
2005
- 2005-09-21 FI FI20050941A patent/FI118842B/fi active IP Right Grant
-
2006
- 2006-08-10 LU LU91273C patent/LU91273I2/fr unknown
- 2006-08-11 NL NL300240C patent/NL300240I2/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR1001161B (el) | Αναστολη της προσκολλησης των λεμφοκυτταρων στο αγγειακο ενδοθηλιο με τη χρησιμοποιηση μιας αλληλεπιδρασης νεου υποδοχεα εξωκυτταρικης μητρας-προσδετη. | |
| Mc Grath et al. | Correlation between serum IgG, platelet membrane IgG, and platelet function in hypergammaglobulinaemic states | |
| DE3586619D1 (de) | Haematologische zusammensetzungen als referenz fuer drei populationen von leukocyten, verfahren zu deren herstellung und deren verwendung in ganzbluttestverfahren. | |
| DE69112966D1 (de) | Verfahren zur bestimmung von antiphospholipid antikörpern. | |
| ATE78097T1 (de) | Verfahren zur bestimmung von mimitopen. | |
| NL300222I2 (nl) | Unieke antigene epitopen op igE-dragende B-lymfocyten. | |
| DE3750989D1 (de) | Bioverträglichkeit harter flächen. | |
| DE69019795D1 (de) | Verfahren zur Feststellung der Empfindlichkeit von HIV-1 für Zidovudine und dazu geeignete Oligonukleotide. | |
| DK21985A (da) | Monoklonale antistoffer mod ikke-smaacellet lungecancer | |
| DE69927831D1 (de) | Modulierung von gedächtnis-effector t-zellen unter verwendung eines cd2-bindungsagentes | |
| AT368854B (de) | Vorrichtung zur variablen verstaerkung der elastischen abstuetzkraefte in beliebigen partialbereichen von liegemoebeln mit quer zur liegemoebelachse angeordneten federleisten | |
| Gurewich et al. | Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin | |
| ATE205600T1 (de) | Leukozytadhaesiontest | |
| Schur | Complement studies of sera and other biologic fluids | |
| DE3852227D1 (de) | Immunologisches Nachweisverfahren für Herbizide. | |
| EA199800352A1 (ru) | ПОЛИПЕПТИД ХЕМОКИНА β-8 (ВАРИАНТЫ) И СПОСОБ ЕГО ПОЛУЧЕНИЯ, КОМПОЗИЦИИ ПОЛИПЕПТИДОВ, ВЕКТОР, КЛЕТКА-ХОЗЯИН, АГОНИСТ И АНТАГОНИСТ, ВСЕ - УПОМЯНУТОГО ПОЛИПЕПТИДА, И СПОСОБ ИДЕНТИФИКАЦИИ ПОСЛЕДНЕГО, СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В Хк-β-8 (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В ПОДАВЛЕНИИ Хк-β-8, СПОСОБ ДИАГНОСТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПРЕДРАСПОЛОЖЕННОСТИ К ЗАБОЛЕВАНИЮ, ОБУСЛОВЛЕННОМУ НЕДОСТАТОЧНОЙ ЭКСПРЕССИЕЙ ПОЛИПЕПТИДА | |
| O'Brien | Neuronal adhesion molecules signal through FGF receptor | |
| BR8106454A (pt) | Suporte para saco de drenagem de liquidos corporais bem como aparelho para o recebimento e coleta de urina ou outro liquido corporal | |
| NO963910L (no) | Fremgangsmåte for bestemmelse av en suppressorkomponent av human immunstatus og en måte for gjennomföring | |
| Grützner et al. | High frequencies of PMN-MDSCs are associated with low suppressive capacity in advanced stages of HIV-1 infection | |
| Quan et al. | Spontaneous and cytokine induced basophil adhesion evaluated by microtiter assay | |
| OHTAKA | EFFECT OF ACUPUNCTURE UPON PAIN IN HANSEN'S DISEASE | |
| Davisson | Invisible owners of painted ladies and other homes: Women property owners in Nevada City, California, 1856-1876. | |
| Bean et al. | Factors That Affect the Results of Microcytotoxicity Testing in Man 1, 2, 3 | |
| Fassbender | Reactions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Right expired |